Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014 (2014), Article ID 278917, 9 pages
http://dx.doi.org/10.1155/2014/278917
Review Article

The Possibility of Traditional Chinese Medicine as Maintenance Therapy for Advanced Nonsmall Cell Lung Cancer

Oncology Department, Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University, 23 Meishuguanhou Street, Dongcheng District, Beijing 100010, China

Received 14 April 2014; Revised 11 July 2014; Accepted 16 July 2014; Published 4 August 2014

Academic Editor: Senthamil R. Selvan

Copyright © 2014 Weiru Xu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Guo, Z. L. Huang, P. Yu, and K. Li, “Trends in cancer mortality in China: an update,” Annals of Oncology, vol. 23, no. 10, pp. 2755–2762, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Siegel, D. Naishadham, and A. Jemal, “Cancer statistics, 2013,” CA Cancer Journal for Clinicians, vol. 63, no. 1, pp. 11–30, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Zarogoulidis, P. Zarogoulidis, K. Darwiche et al., “Treatment of non-small cell lung cancer (NSCLC),” Journal of Thoracic Disease, vol. 5, supplement 4, pp. S389–S396, 2013. View at Google Scholar
  4. J. H. Schiller, D. Harrington, C. P. Belani et al., “Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer,” The New England Journal of Medicine, vol. 346, no. 2, pp. 92–98, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. G. V. Scagliotti, F. de Marinis, M. Rinaldi et al., “Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer,” Journal of Clinical Oncology, vol. 20, no. 21, pp. 4285–4291, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Fossella, J. R. Pereira, J. von Pawel et al., “Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 Study Group,” Journal of Clinical Oncology, vol. 21, no. 16, pp. 3016–3024, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Lee and C. Chung, “Update on the evidence regarding maintenance therapy,” Tuberculosis and Respiratory Diseases, vol. 76, no. 1, pp. 1–7, 2014. View at Publisher · View at Google Scholar
  8. P. Fidias and S. Novello, “Strategies for prolonged therapy in patients with advanced non-small-cell lung cancer,” Journal of Clinical Oncology, vol. 28, no. 34, pp. 5116–5123, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. T. E. Stinchcombe and M. A. Socinski, “Treatment paradigms for advanced stage non-small cell lung cancer in the era of multiple lines of therapy,” Journal of Thoracic Oncology, vol. 4, no. 2, pp. 243–250, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. C. P. Belani, T. Brodowicz, T. E. Ciuleanu et al., “Quality of life in patients with advanced non-small-cell lung cancer given maintenance treatment with pemetrexed versus placebo (H3E-MC-JMEN): results from a randomised, double-blind, phase 3 study,” The Lancet Oncology, vol. 13, no. 3, pp. 292–299, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. H. S. Boon, F. Olatunde, and S. M. Zick, “Trends in complementary/alternative medicine use by breast cancer survivors: Comparing survey data from 1998 and 2005,” BMC Women's Health, vol. 7, article 4, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Jia, “Cancer complementary and alternative medicine research at the US National Cancer Institute,” Chinese Journal of Integrative Medicine, vol. 18, no. 5, pp. 325–332, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. L. H. Yoder, “Let's talk “cancer prevention”,” Medsurg Nursing, vol. 14, no. 3, pp. 195–198, 2005. View at Google Scholar · View at Scopus
  14. C. Gridelli, F. de Marinis, M. Di Maio et al., “Maintenance treatment of advanced non-small-cell lung cancer: results of an international expert panel meeting of the Italian association of thoracic oncology,” Lung Cancer, vol. 76, no. 3, pp. 269–279, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. J. H. Goldie and A. J. Coldman, “A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate,” Cancer Treatment Reports, vol. 63, no. 11-12, pp. 1727–1733, 1979. View at Google Scholar · View at Scopus
  16. L. Paz-Ares, F. de Marinis, M. Dediu et al., “Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial,” The Lancet Oncology, vol. 13, no. 3, pp. 247–255, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. L. G. Paz-Ares, F. de Marinis, M. Dediu et al., “PARAMOUNT: final overall survival results of the phase III study of maintenance pemetrexed versus placebo immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer,” Journal of Clinical Oncology, vol. 31, no. 23, pp. 2895–2902, 2013. View at Google Scholar
  18. M. Pérol, C. Chouaid, D. Pérol et al., “Randomized, phase III study of gemcitabine or erlotinib maintenance therapy versus observation,with predefined second-line treatment, after cisplatin-gemcitabine induction chemotherapy in advanced non-small-cell lung cancer,” Journal of Clinical Oncology, vol. 30, no. 28, pp. 3516–3524, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. R. C. Yu, “The effects and prospect of traditional Chinese medicine in the prevention and treatment of cancer,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 27, no. 5, pp. 389–390, 2007. View at Google Scholar
  20. R. C. Yu and W. J. Tang, “Balance therapy in the application of integrative cancer therapy,” Oncology Progress, vol. 2, no. 6, pp. 438–450, 2004. View at Google Scholar
  21. J. X. Liu, “Anti-cancer therapies of yin-yang balance and tonifying in the application of cancer treatment,” Jiang Su Zhong Yi Yao, vol. 40, no. 9, pp. 1–2, 2008. View at Google Scholar
  22. H. S. Lin and Y. Zhang, “Evidence-based medical study of TCM on non small cell lung cancer,” World Science and Technology—Modernization of Traditional Chinese Medicine and Materia Medica, vol. 10, no. 4, pp. 121–125, 2008. View at Google Scholar
  23. S. R. Ren, D. B. Liao, X. Q. Zhou, and J. Wang, “Shenqi Fuzheng Injection combined with radiotherapy on treating 34 senile advanced non small cell lung cancer patients,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 26, no. 10, p. 876, 2006. View at Google Scholar
  24. X. Z. Lan and Y. H. Jiang, “Radiotherapy combined with traditional Chinese medicine on treating 26 senile advanced non small cell lung cancer,” Zhong Yi Za Zhi, vol. 43, no. 2, pp. 125–126, 2002. View at Google Scholar
  25. H. B. Cai, F. G. Dai, Q. F. Min, M. Shi, J. X. Liao, and R. C. Luo, “Clinical study of the effects of radiotherapy in combination with traditional Chinese medicine on non-small cell lung cancer,” Journal of First Military Medical University, vol. 22, no. 12, pp. 1112–1114, 2001. View at Google Scholar
  26. H. S. Lin and Y. Zhang, “The review and the prospect of TCM oncology,” Global Traditional Chinese Medicine, vol. 2, no. 5, pp. 321–326, 2009. View at Google Scholar
  27. Z. F. Chen, C. Z. Li, S. X. Liu, J. Hou, and J. M. Wang, “Meta analysis on primary non-small cell lung carcinoma treated by TCM in China,” Zhong Yi Za Zhi, vol. 40, no. 5, 1995. View at Google Scholar
  28. B. K. Piao, W. X. Tang, Z. Q. Zhang, H. S. Lin, F. W. Duan, and G. Q. Yu, “Feiliuping Gao in the treatment of advanced primary lung cancer, an analysis of 339 cases,” Zhong Yi Za Zhi, no. 4, pp. 21–23, 1991. View at Google Scholar
  29. P. W. Li, D. Z. Zhang, Y. X. Hao et al., “Pingfei Fang in the treatment of 109 non small cell lung cancer patients,” Zhong Yi Za Zhi, vol. 36, no. 2, pp. 87–88, 1995. View at Google Scholar
  30. M. Q. Pan, Y. H. Li, J. A. Liu et al., “Feifu Fang in the treatment of 80 advanced primary bronchial squamous cancer patients controlled with chemotherapy,” Zhong Guo Yi Yao Xue Bao, vol. 5, no. 3, pp. 19–23, 1990. View at Google Scholar
  31. G. W. Yang, X. M. Wang, D. Han et al., “Study on TCM comprehensive therapy in the treatment of advanced non-small cell lung cancer,” Zhong Guo Zhong Yi Yao Xin Xi Za Zhi, vol. 12, no. 9, pp. 11–13, 2005. View at Google Scholar
  32. D. H. Zhou, L. Z. Lin, Y. Q. Zhou et al., “Effect of Chinese herbal medicine in prolonging median survival time in patients with non small cell lung cancer,” Guang Zhou Zhong Yi Yao Da Xue Xue Bao, vol. 22, no. 4, pp. 255–258, 2005. View at Google Scholar
  33. M. Z. Zhu and W. Y. Wu, “Specialized TCM prescription integrated with chemotherapy in the treatment of stages III-IV non-small cell lung cancer: a meta analysis,” Tumor, vol. 33, no. 6, pp. 534–545, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Zhang, W. Hou, and H. S. Lin, “The achievements and thinking of traditional Chinese medicine in the treatment of cancer,” Zhong Yi Za Zhi, vol. 55, no. 6, pp. 523–525, 2014. View at Google Scholar
  35. B. R. Cassileth, N. Rizvi, G. Deng et al., “Safety and pharmacokinetic trial of docetaxel plus an Astragalus-based herbal formula for non-small cell lung cancer patients,” Cancer Chemotherapy and Pharmacology, vol. 65, no. 1, pp. 67–71, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. J. H. Li, “A clinical comparative study on traditional Chinese Medicine serving as consolidation treatment in patients with advanced non-small cell lung cancer,” Chinese Journal of Lung Cancer, vol. 10, no. 6, pp. 520–522, 2007. View at Google Scholar · View at Scopus
  37. Z. Q. Liu, Q. T. Chen, Y. Li, Y. Song, and H. L. Sun, “Influences of Roucongrong on hematopoietic function and immune function in tumor-bearing mice after chemotherapy,” Journal of Beijing University of Traditional Chinese Medicine, vol. 33, no. 11, pp. 758–761, 2010. View at Google Scholar
  38. Q. Zhang, X. M. Wang, G. W. Yang et al., “Guben Xiaoliu Capsule combined with Folfox4 regimen in the treatment of advanced colorectal cancer,” Beijing Journal of Traditional Chinese Medicine, vol. 29, no. 4, pp. 255–258, 2010. View at Google Scholar
  39. H. P. Yao, T. Cui, Q. W. Zheng, and W. Y. Feng, “Antitumor and immunological regulation effects of Qibai capsule on mice bearing uterine cervical carcinoma,” Chinese Journal of Hospital Pharmacy, vol. 33, no. 19, pp. 1567–1569, 2013. View at Google Scholar
  40. S. R. Zhuang, H. F. Chiu, S. L. Chen et al., “Effects of a Chinese medical herbs complex on cellular immunity and toxicity-related conditions of breast cancer patients,” British Journal of Nutrition, vol. 107, no. 5, pp. 712–718, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Zhuang, S. Chen, J. Tsai et al., “Effect of citronellol and the Chinese medical herb complex on cellular immunity of cancer patients receiving chemotherapy/radiotherapy,” Phytotherapy Research, vol. 23, no. 6, pp. 785–790, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Li, H. S. Lin, W. Hou, and B. J. Hua, “Idea and strategy of traditional Chinese medicine treatment for cancer,” China Cancer, vol. 19, no. 11, pp. 735–738, 2010. View at Google Scholar
  43. K. Takeda, T. Hida, T. Sato et al., “Randomized phase III trial of platinum-doublet chemotherapy followed by gefitinib compared with continued platinum-doublet chemotherapy in Japanese patients with advanced non-small-cell lung cancer: results of a West Japan Thoracic Oncology Group Trial (WJTOG0203),” Journal of Clinical Oncology, vol. 28, no. 5, pp. 753–760, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. Z. Liu, Z. Yu, X. Ouyang et al., “Effects of Feitai Capsule on quality of life in patients with advanced non-small-cell lung cancer: a randomized controlled trial,” Journal of Chinese Integrative Medicine, vol. 7, no. 7, pp. 611–615, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. X. S. Chai, C. X. He, W. Y. Wu, and L. N. Li, “Xiaoji Yin as maintenance therapy in the treatment of survival time of advanced non small cell lung cancer,” Shi Zhen Guo Yi Guo Yao, vol. 22, no. 10, pp. 2547–2548, 2011. View at Google Scholar
  46. Y. Jiang, L. S. Liu, C. J. Li, J. H. Tian, L. P. Shen, and H. G. Li, “Effect of Chinese medicine comprehensive regimen as the maintenance therapy on time to progression and quality of life of patients with advanced non-small-cell lung cancer,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 31, no. 10, pp. 1311–1316, 2011. View at Google Scholar · View at Scopus
  47. C. X. Xi, G. Q. Yang, Z. G. Li, and W. X. Tao, “Clinical observations of maintenance therapy with Hechan Pian for patients in intermediate and advanced non small cell lung cancer,” Zhong Liu Fang Zhi Yan Jiu, vol. 38, no. 10, pp. 1170–1172, 2011. View at Google Scholar
  48. D. X. Zeng, Y. Z. Bi, G. F. Sheng, Y. Z. Dong, and H. L. Song, “Effectiveness and safety of single-agent ginsenoside Rg3 maintenance therapy after response to first-line chemotherapy in patients with advanced non small cell lung cancer,” Oncology Progress, vol. 11, no. 6, pp. 554–558, 2013. View at Google Scholar
  49. C. Q. Yang, “Clinical research on adjuvant chemotherapy and maintenance therapy of Fuzheng Xiaoji Yin treatment of non small cell lung cancer in middle and advanced stage,” Zhong Yi Xue Bao, vol. 28, no. 187, pp. 1782–1784, 2013. View at Google Scholar
  50. J. R. Liang and L. H. Zhang, “Rongyan Capsule as maintenance therapy on the effects of survival time of advanced non small cell lung cancer,” Si Chuan Zhong Yi, vol. 31, no. 1, pp. 100–101, 2013. View at Google Scholar
  51. L. Wang, Z. X. Sun, G. Q. Feng, and S. J. Ma, “Effect of maintenance treatment by traditional Chinese medicine syndrome differentiation on life quality and progress-free survival of patients with advanced non small cell lung cancer after chemotherapy,” Zhong Guo Shi Yan Fang Ji Xue Za Zhi, vol. 19, no. 13, pp. 319–322, 2013. View at Google Scholar
  52. Y. F. Wu, S. Xu, J. Jia, and G. Wang, “Effect of maintenance treatment with Shenyi Capsule on survival period of advanced non small cell lung cancer patients after induction chemotherapy,” Guang Zhou Zhong Yi Yao Da Xue Xue Bao, vol. 31, pp. 40–43, 2014. View at Google Scholar